The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a Memorandum of Understanding (MoU) to strengthen their collaboration in vaccine innovation and explore the establishment of a Vaccine Innovation Centre in Abu Dhabi.
The initiative aims to advance joint efforts in research, development, and healthcare innovation within the emirate.
The DoH-Sanofi collaboration would strengthen capabilities across AI-enabled vaccine discovery, mRNA research, clinical development, and manufacturing, and support regional and global preparedness for future public health challenges.
Operating within Abu Dhabi’s Health, Endurance, Longevity, and Medicine (HELM) Cluster, the collaboration intends to bring together scientific research, clinical infrastructure, academic expertise, enabling regulation, and advanced manufacturing within a single ecosystem.
Dr. Noura Al Ghaithi Undersecretary DoH-Abu Dhabi
“Through our partnership with Sanofi, we are bringing together AI, scientific research, clinical expertise, advanced manufacturing, and enabling regulation within a single ecosystem designed to accelerate the journey from discovery to impact. This partnership reflects Abu Dhabi’s commitment to creating an environment where innovators can build, test, and scale solutions that improve lives, strengthen preparedness, and advance health outcomes for communities around the world.”
Baptiste de Clarens, General Manager Vaccines, Greater Gulf at Sanofi, stated that, “We are proud to deepen our collaboration with the DoH. Vaccine innovation today is being reshaped by artificial intelligence, by advances in mRNA science, and by new models that connect discovery, development, and manufacturing. We look forward to exploring how these capabilities can be brought together to accelerate the journey from discovery to the patients.”
The planned Vaccine Innovation Centre is expected to strengthen Abu Dhabi’s contribution to global health security while supporting the development of local scientific talent, advanced manufacturing capabilities, and next-generation vaccine innovation.
Through the advancement of vaccine research, development, and manufacturing capabilities in the region, the center will help expand access to advanced vaccines and strengthen preparedness for future public health challenges, as per the statement.
